Global Life Science CDMO Supply, Demand and Key Producers, 2024-2030
The global Life Science CDMO market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Life Science CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Life Science CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Life Science CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Life Science CDMO total market, 2019-2030, (USD Million)
Global Life Science CDMO total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Life Science CDMO total market, key domestic companies and share, (USD Million)
Global Life Science CDMO revenue by player and market share 2019-2024, (USD Million)
Global Life Science CDMO total market by Type, CAGR, 2019-2030, (USD Million)
Global Life Science CDMO total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Life Science CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Thermo Fisher Scientific, Catalent, WuXi Biologics, Samsung Biologics, Siegfried, Fujifilm Diosynth Biotechnologies, Lars Petersen and Recipharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Life Science CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Life Science CDMO Market, By Region:
1. How big is the global Life Science CDMO market?
2. What is the demand of the global Life Science CDMO market?
3. What is the year over year growth of the global Life Science CDMO market?
4. What is the total value of the global Life Science CDMO market?
5. Who are the major players in the global Life Science CDMO market?
This report studies the global Life Science CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Life Science CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Life Science CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Life Science CDMO total market, 2019-2030, (USD Million)
Global Life Science CDMO total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Life Science CDMO total market, key domestic companies and share, (USD Million)
Global Life Science CDMO revenue by player and market share 2019-2024, (USD Million)
Global Life Science CDMO total market by Type, CAGR, 2019-2030, (USD Million)
Global Life Science CDMO total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Life Science CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Thermo Fisher Scientific, Catalent, WuXi Biologics, Samsung Biologics, Siegfried, Fujifilm Diosynth Biotechnologies, Lars Petersen and Recipharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Life Science CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Life Science CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Active Pharmaceutical Ingredient (API) CDMO
- Biologics CDMO
- Finished Dosage Form (FDF) CDMO
- Others
- Pharmaceutical
- Clinical
- Research
- Lonza Group
- Thermo Fisher Scientific
- Catalent
- WuXi Biologics
- Samsung Biologics
- Siegfried
- Fujifilm Diosynth Biotechnologies
- Lars Petersen
- Recipharm
- Boehringer Ingelheim
- MilliporeSigma
- Aenova Group
- AGC Parma Chemicals
- GenScript
- Novartis
- Sai Life Sciences
1. How big is the global Life Science CDMO market?
2. What is the demand of the global Life Science CDMO market?
3. What is the year over year growth of the global Life Science CDMO market?
4. What is the total value of the global Life Science CDMO market?
5. Who are the major players in the global Life Science CDMO market?
1 SUPPLY SUMMARY
1.1 Life Science CDMO Introduction
1.2 World Life Science CDMO Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Life Science CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Life Science CDMO Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Life Science CDMO Market Size (2019-2030)
1.3.3 China Life Science CDMO Market Size (2019-2030)
1.3.4 Europe Life Science CDMO Market Size (2019-2030)
1.3.5 Japan Life Science CDMO Market Size (2019-2030)
1.3.6 South Korea Life Science CDMO Market Size (2019-2030)
1.3.7 ASEAN Life Science CDMO Market Size (2019-2030)
1.3.8 India Life Science CDMO Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Life Science CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Life Science CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Life Science CDMO Consumption Value (2019-2030)
2.2 World Life Science CDMO Consumption Value by Region
2.2.1 World Life Science CDMO Consumption Value by Region (2019-2024)
2.2.2 World Life Science CDMO Consumption Value Forecast by Region (2025-2030)
2.3 United States Life Science CDMO Consumption Value (2019-2030)
2.4 China Life Science CDMO Consumption Value (2019-2030)
2.5 Europe Life Science CDMO Consumption Value (2019-2030)
2.6 Japan Life Science CDMO Consumption Value (2019-2030)
2.7 South Korea Life Science CDMO Consumption Value (2019-2030)
2.8 ASEAN Life Science CDMO Consumption Value (2019-2030)
2.9 India Life Science CDMO Consumption Value (2019-2030)
3 WORLD LIFE SCIENCE CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Life Science CDMO Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Life Science CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Life Science CDMO in 2023
3.2.3 Global Concentration Ratios (CR8) for Life Science CDMO in 2023
3.3 Life Science CDMO Company Evaluation Quadrant
3.4 Life Science CDMO Market: Overall Company Footprint Analysis
3.4.1 Life Science CDMO Market: Region Footprint
3.4.2 Life Science CDMO Market: Company Product Type Footprint
3.4.3 Life Science CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Life Science CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Life Science CDMO Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Life Science CDMO Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Life Science CDMO Consumption Value Comparison
4.2.1 United States VS China: Life Science CDMO Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Life Science CDMO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Life Science CDMO Companies and Market Share, 2019-2024
4.3.1 United States Based Life Science CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Life Science CDMO Revenue, (2019-2024)
4.4 China Based Companies Life Science CDMO Revenue and Market Share, 2019-2024
4.4.1 China Based Life Science CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Life Science CDMO Revenue, (2019-2024)
4.5 Rest of World Based Life Science CDMO Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Life Science CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Life Science CDMO Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Life Science CDMO Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Active Pharmaceutical Ingredient (API) CDMO
5.2.2 Biologics CDMO
5.2.3 Finished Dosage Form (FDF) CDMO
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Life Science CDMO Market Size by Type (2019-2024)
5.3.2 World Life Science CDMO Market Size by Type (2025-2030)
5.3.3 World Life Science CDMO Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Life Science CDMO Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical
6.2.2 Clinical
6.2.3 Research
6.3 Market Segment by Application
6.3.1 World Life Science CDMO Market Size by Application (2019-2024)
6.3.2 World Life Science CDMO Market Size by Application (2025-2030)
6.3.3 World Life Science CDMO Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Lonza Group
7.1.1 Lonza Group Details
7.1.2 Lonza Group Major Business
7.1.3 Lonza Group Life Science CDMO Product and Services
7.1.4 Lonza Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Lonza Group Recent Developments/Updates
7.1.6 Lonza Group Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific Life Science CDMO Product and Services
7.2.4 Thermo Fisher Scientific Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Life Science CDMO Product and Services
7.3.4 Catalent Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 WuXi Biologics
7.4.1 WuXi Biologics Details
7.4.2 WuXi Biologics Major Business
7.4.3 WuXi Biologics Life Science CDMO Product and Services
7.4.4 WuXi Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 WuXi Biologics Recent Developments/Updates
7.4.6 WuXi Biologics Competitive Strengths & Weaknesses
7.5 Samsung Biologics
7.5.1 Samsung Biologics Details
7.5.2 Samsung Biologics Major Business
7.5.3 Samsung Biologics Life Science CDMO Product and Services
7.5.4 Samsung Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Samsung Biologics Recent Developments/Updates
7.5.6 Samsung Biologics Competitive Strengths & Weaknesses
7.6 Siegfried
7.6.1 Siegfried Details
7.6.2 Siegfried Major Business
7.6.3 Siegfried Life Science CDMO Product and Services
7.6.4 Siegfried Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Siegfried Recent Developments/Updates
7.6.6 Siegfried Competitive Strengths & Weaknesses
7.7 Fujifilm Diosynth Biotechnologies
7.7.1 Fujifilm Diosynth Biotechnologies Details
7.7.2 Fujifilm Diosynth Biotechnologies Major Business
7.7.3 Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Services
7.7.4 Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
7.7.6 Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.8 Lars Petersen
7.8.1 Lars Petersen Details
7.8.2 Lars Petersen Major Business
7.8.3 Lars Petersen Life Science CDMO Product and Services
7.8.4 Lars Petersen Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Lars Petersen Recent Developments/Updates
7.8.6 Lars Petersen Competitive Strengths & Weaknesses
7.9 Recipharm
7.9.1 Recipharm Details
7.9.2 Recipharm Major Business
7.9.3 Recipharm Life Science CDMO Product and Services
7.9.4 Recipharm Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Recipharm Recent Developments/Updates
7.9.6 Recipharm Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Life Science CDMO Product and Services
7.10.4 Boehringer Ingelheim Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 MilliporeSigma
7.11.1 MilliporeSigma Details
7.11.2 MilliporeSigma Major Business
7.11.3 MilliporeSigma Life Science CDMO Product and Services
7.11.4 MilliporeSigma Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 MilliporeSigma Recent Developments/Updates
7.11.6 MilliporeSigma Competitive Strengths & Weaknesses
7.12 Aenova Group
7.12.1 Aenova Group Details
7.12.2 Aenova Group Major Business
7.12.3 Aenova Group Life Science CDMO Product and Services
7.12.4 Aenova Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Aenova Group Recent Developments/Updates
7.12.6 Aenova Group Competitive Strengths & Weaknesses
7.13 AGC Parma Chemicals
7.13.1 AGC Parma Chemicals Details
7.13.2 AGC Parma Chemicals Major Business
7.13.3 AGC Parma Chemicals Life Science CDMO Product and Services
7.13.4 AGC Parma Chemicals Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 AGC Parma Chemicals Recent Developments/Updates
7.13.6 AGC Parma Chemicals Competitive Strengths & Weaknesses
7.14 GenScript
7.14.1 GenScript Details
7.14.2 GenScript Major Business
7.14.3 GenScript Life Science CDMO Product and Services
7.14.4 GenScript Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 GenScript Recent Developments/Updates
7.14.6 GenScript Competitive Strengths & Weaknesses
7.15 Novartis
7.15.1 Novartis Details
7.15.2 Novartis Major Business
7.15.3 Novartis Life Science CDMO Product and Services
7.15.4 Novartis Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Novartis Recent Developments/Updates
7.15.6 Novartis Competitive Strengths & Weaknesses
7.16 Sai Life Sciences
7.16.1 Sai Life Sciences Details
7.16.2 Sai Life Sciences Major Business
7.16.3 Sai Life Sciences Life Science CDMO Product and Services
7.16.4 Sai Life Sciences Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Sai Life Sciences Recent Developments/Updates
7.16.6 Sai Life Sciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Life Science CDMO Industry Chain
8.2 Life Science CDMO Upstream Analysis
8.3 Life Science CDMO Midstream Analysis
8.4 Life Science CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Life Science CDMO Introduction
1.2 World Life Science CDMO Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Life Science CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Life Science CDMO Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Life Science CDMO Market Size (2019-2030)
1.3.3 China Life Science CDMO Market Size (2019-2030)
1.3.4 Europe Life Science CDMO Market Size (2019-2030)
1.3.5 Japan Life Science CDMO Market Size (2019-2030)
1.3.6 South Korea Life Science CDMO Market Size (2019-2030)
1.3.7 ASEAN Life Science CDMO Market Size (2019-2030)
1.3.8 India Life Science CDMO Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Life Science CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Life Science CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Life Science CDMO Consumption Value (2019-2030)
2.2 World Life Science CDMO Consumption Value by Region
2.2.1 World Life Science CDMO Consumption Value by Region (2019-2024)
2.2.2 World Life Science CDMO Consumption Value Forecast by Region (2025-2030)
2.3 United States Life Science CDMO Consumption Value (2019-2030)
2.4 China Life Science CDMO Consumption Value (2019-2030)
2.5 Europe Life Science CDMO Consumption Value (2019-2030)
2.6 Japan Life Science CDMO Consumption Value (2019-2030)
2.7 South Korea Life Science CDMO Consumption Value (2019-2030)
2.8 ASEAN Life Science CDMO Consumption Value (2019-2030)
2.9 India Life Science CDMO Consumption Value (2019-2030)
3 WORLD LIFE SCIENCE CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Life Science CDMO Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Life Science CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Life Science CDMO in 2023
3.2.3 Global Concentration Ratios (CR8) for Life Science CDMO in 2023
3.3 Life Science CDMO Company Evaluation Quadrant
3.4 Life Science CDMO Market: Overall Company Footprint Analysis
3.4.1 Life Science CDMO Market: Region Footprint
3.4.2 Life Science CDMO Market: Company Product Type Footprint
3.4.3 Life Science CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Life Science CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Life Science CDMO Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Life Science CDMO Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Life Science CDMO Consumption Value Comparison
4.2.1 United States VS China: Life Science CDMO Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Life Science CDMO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Life Science CDMO Companies and Market Share, 2019-2024
4.3.1 United States Based Life Science CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Life Science CDMO Revenue, (2019-2024)
4.4 China Based Companies Life Science CDMO Revenue and Market Share, 2019-2024
4.4.1 China Based Life Science CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Life Science CDMO Revenue, (2019-2024)
4.5 Rest of World Based Life Science CDMO Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Life Science CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Life Science CDMO Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Life Science CDMO Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Active Pharmaceutical Ingredient (API) CDMO
5.2.2 Biologics CDMO
5.2.3 Finished Dosage Form (FDF) CDMO
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Life Science CDMO Market Size by Type (2019-2024)
5.3.2 World Life Science CDMO Market Size by Type (2025-2030)
5.3.3 World Life Science CDMO Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Life Science CDMO Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical
6.2.2 Clinical
6.2.3 Research
6.3 Market Segment by Application
6.3.1 World Life Science CDMO Market Size by Application (2019-2024)
6.3.2 World Life Science CDMO Market Size by Application (2025-2030)
6.3.3 World Life Science CDMO Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Lonza Group
7.1.1 Lonza Group Details
7.1.2 Lonza Group Major Business
7.1.3 Lonza Group Life Science CDMO Product and Services
7.1.4 Lonza Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Lonza Group Recent Developments/Updates
7.1.6 Lonza Group Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific Life Science CDMO Product and Services
7.2.4 Thermo Fisher Scientific Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Catalent
7.3.1 Catalent Details
7.3.2 Catalent Major Business
7.3.3 Catalent Life Science CDMO Product and Services
7.3.4 Catalent Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Catalent Recent Developments/Updates
7.3.6 Catalent Competitive Strengths & Weaknesses
7.4 WuXi Biologics
7.4.1 WuXi Biologics Details
7.4.2 WuXi Biologics Major Business
7.4.3 WuXi Biologics Life Science CDMO Product and Services
7.4.4 WuXi Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 WuXi Biologics Recent Developments/Updates
7.4.6 WuXi Biologics Competitive Strengths & Weaknesses
7.5 Samsung Biologics
7.5.1 Samsung Biologics Details
7.5.2 Samsung Biologics Major Business
7.5.3 Samsung Biologics Life Science CDMO Product and Services
7.5.4 Samsung Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Samsung Biologics Recent Developments/Updates
7.5.6 Samsung Biologics Competitive Strengths & Weaknesses
7.6 Siegfried
7.6.1 Siegfried Details
7.6.2 Siegfried Major Business
7.6.3 Siegfried Life Science CDMO Product and Services
7.6.4 Siegfried Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Siegfried Recent Developments/Updates
7.6.6 Siegfried Competitive Strengths & Weaknesses
7.7 Fujifilm Diosynth Biotechnologies
7.7.1 Fujifilm Diosynth Biotechnologies Details
7.7.2 Fujifilm Diosynth Biotechnologies Major Business
7.7.3 Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Services
7.7.4 Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
7.7.6 Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.8 Lars Petersen
7.8.1 Lars Petersen Details
7.8.2 Lars Petersen Major Business
7.8.3 Lars Petersen Life Science CDMO Product and Services
7.8.4 Lars Petersen Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Lars Petersen Recent Developments/Updates
7.8.6 Lars Petersen Competitive Strengths & Weaknesses
7.9 Recipharm
7.9.1 Recipharm Details
7.9.2 Recipharm Major Business
7.9.3 Recipharm Life Science CDMO Product and Services
7.9.4 Recipharm Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Recipharm Recent Developments/Updates
7.9.6 Recipharm Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Life Science CDMO Product and Services
7.10.4 Boehringer Ingelheim Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 MilliporeSigma
7.11.1 MilliporeSigma Details
7.11.2 MilliporeSigma Major Business
7.11.3 MilliporeSigma Life Science CDMO Product and Services
7.11.4 MilliporeSigma Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 MilliporeSigma Recent Developments/Updates
7.11.6 MilliporeSigma Competitive Strengths & Weaknesses
7.12 Aenova Group
7.12.1 Aenova Group Details
7.12.2 Aenova Group Major Business
7.12.3 Aenova Group Life Science CDMO Product and Services
7.12.4 Aenova Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Aenova Group Recent Developments/Updates
7.12.6 Aenova Group Competitive Strengths & Weaknesses
7.13 AGC Parma Chemicals
7.13.1 AGC Parma Chemicals Details
7.13.2 AGC Parma Chemicals Major Business
7.13.3 AGC Parma Chemicals Life Science CDMO Product and Services
7.13.4 AGC Parma Chemicals Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 AGC Parma Chemicals Recent Developments/Updates
7.13.6 AGC Parma Chemicals Competitive Strengths & Weaknesses
7.14 GenScript
7.14.1 GenScript Details
7.14.2 GenScript Major Business
7.14.3 GenScript Life Science CDMO Product and Services
7.14.4 GenScript Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 GenScript Recent Developments/Updates
7.14.6 GenScript Competitive Strengths & Weaknesses
7.15 Novartis
7.15.1 Novartis Details
7.15.2 Novartis Major Business
7.15.3 Novartis Life Science CDMO Product and Services
7.15.4 Novartis Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Novartis Recent Developments/Updates
7.15.6 Novartis Competitive Strengths & Weaknesses
7.16 Sai Life Sciences
7.16.1 Sai Life Sciences Details
7.16.2 Sai Life Sciences Major Business
7.16.3 Sai Life Sciences Life Science CDMO Product and Services
7.16.4 Sai Life Sciences Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Sai Life Sciences Recent Developments/Updates
7.16.6 Sai Life Sciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Life Science CDMO Industry Chain
8.2 Life Science CDMO Upstream Analysis
8.3 Life Science CDMO Midstream Analysis
8.4 Life Science CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Life Science CDMO Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Life Science CDMO Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Life Science CDMO Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Life Science CDMO Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Life Science CDMO Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Life Science CDMO Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Life Science CDMO Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Life Science CDMO Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Life Science CDMO Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Life Science CDMO Players in 2023
Table 12. World Life Science CDMO Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Life Science CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Life Science CDMO Player
Table 15. Life Science CDMO Market: Company Product Type Footprint
Table 16. Life Science CDMO Market: Company Product Application Footprint
Table 17. Life Science CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Life Science CDMO Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Life Science CDMO Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Life Science CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Life Science CDMO Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Life Science CDMO Revenue Market Share (2019-2024)
Table 23. China Based Life Science CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Life Science CDMO Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Life Science CDMO Revenue Market Share (2019-2024)
Table 26. Rest of World Based Life Science CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Life Science CDMO Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Life Science CDMO Revenue Market Share (2019-2024)
Table 29. World Life Science CDMO Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Life Science CDMO Market Size by Type (2019-2024) & (USD Million)
Table 31. World Life Science CDMO Market Size by Type (2025-2030) & (USD Million)
Table 32. World Life Science CDMO Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Life Science CDMO Market Size by Application (2019-2024) & (USD Million)
Table 34. World Life Science CDMO Market Size by Application (2025-2030) & (USD Million)
Table 35. Lonza Group Basic Information, Area Served and Competitors
Table 36. Lonza Group Major Business
Table 37. Lonza Group Life Science CDMO Product and Services
Table 38. Lonza Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Lonza Group Recent Developments/Updates
Table 40. Lonza Group Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Life Science CDMO Product and Services
Table 44. Thermo Fisher Scientific Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Life Science CDMO Product and Services
Table 50. Catalent Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. WuXi Biologics Basic Information, Area Served and Competitors
Table 54. WuXi Biologics Major Business
Table 55. WuXi Biologics Life Science CDMO Product and Services
Table 56. WuXi Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. WuXi Biologics Recent Developments/Updates
Table 58. WuXi Biologics Competitive Strengths & Weaknesses
Table 59. Samsung Biologics Basic Information, Area Served and Competitors
Table 60. Samsung Biologics Major Business
Table 61. Samsung Biologics Life Science CDMO Product and Services
Table 62. Samsung Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Samsung Biologics Recent Developments/Updates
Table 64. Samsung Biologics Competitive Strengths & Weaknesses
Table 65. Siegfried Basic Information, Area Served and Competitors
Table 66. Siegfried Major Business
Table 67. Siegfried Life Science CDMO Product and Services
Table 68. Siegfried Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Siegfried Recent Developments/Updates
Table 70. Siegfried Competitive Strengths & Weaknesses
Table 71. Fujifilm Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 72. Fujifilm Diosynth Biotechnologies Major Business
Table 73. Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Services
Table 74. Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Fujifilm Diosynth Biotechnologies Recent Developments/Updates
Table 76. Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 77. Lars Petersen Basic Information, Area Served and Competitors
Table 78. Lars Petersen Major Business
Table 79. Lars Petersen Life Science CDMO Product and Services
Table 80. Lars Petersen Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Lars Petersen Recent Developments/Updates
Table 82. Lars Petersen Competitive Strengths & Weaknesses
Table 83. Recipharm Basic Information, Area Served and Competitors
Table 84. Recipharm Major Business
Table 85. Recipharm Life Science CDMO Product and Services
Table 86. Recipharm Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Recipharm Recent Developments/Updates
Table 88. Recipharm Competitive Strengths & Weaknesses
Table 89. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 90. Boehringer Ingelheim Major Business
Table 91. Boehringer Ingelheim Life Science CDMO Product and Services
Table 92. Boehringer Ingelheim Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Boehringer Ingelheim Recent Developments/Updates
Table 94. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 95. MilliporeSigma Basic Information, Area Served and Competitors
Table 96. MilliporeSigma Major Business
Table 97. MilliporeSigma Life Science CDMO Product and Services
Table 98. MilliporeSigma Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. MilliporeSigma Recent Developments/Updates
Table 100. MilliporeSigma Competitive Strengths & Weaknesses
Table 101. Aenova Group Basic Information, Area Served and Competitors
Table 102. Aenova Group Major Business
Table 103. Aenova Group Life Science CDMO Product and Services
Table 104. Aenova Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Aenova Group Recent Developments/Updates
Table 106. Aenova Group Competitive Strengths & Weaknesses
Table 107. AGC Parma Chemicals Basic Information, Area Served and Competitors
Table 108. AGC Parma Chemicals Major Business
Table 109. AGC Parma Chemicals Life Science CDMO Product and Services
Table 110. AGC Parma Chemicals Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. AGC Parma Chemicals Recent Developments/Updates
Table 112. AGC Parma Chemicals Competitive Strengths & Weaknesses
Table 113. GenScript Basic Information, Area Served and Competitors
Table 114. GenScript Major Business
Table 115. GenScript Life Science CDMO Product and Services
Table 116. GenScript Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. GenScript Recent Developments/Updates
Table 118. GenScript Competitive Strengths & Weaknesses
Table 119. Novartis Basic Information, Area Served and Competitors
Table 120. Novartis Major Business
Table 121. Novartis Life Science CDMO Product and Services
Table 122. Novartis Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Novartis Recent Developments/Updates
Table 124. Sai Life Sciences Basic Information, Area Served and Competitors
Table 125. Sai Life Sciences Major Business
Table 126. Sai Life Sciences Life Science CDMO Product and Services
Table 127. Sai Life Sciences Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 128. Global Key Players of Life Science CDMO Upstream (Raw Materials)
Table 129. Life Science CDMO Typical Customers
LIST OF FIGURE
Figure 1. Life Science CDMO Picture
Figure 2. World Life Science CDMO Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Life Science CDMO Total Market Size (2019-2030) & (USD Million)
Figure 4. World Life Science CDMO Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Life Science CDMO Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 13. Life Science CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 16. World Life Science CDMO Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 18. China Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 23. India Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Life Science CDMO by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Life Science CDMO Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Life Science CDMO Markets in 2023
Figure 27. United States VS China: Life Science CDMO Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Life Science CDMO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Life Science CDMO Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Life Science CDMO Market Size Market Share by Type in 2023
Figure 31. Active Pharmaceutical Ingredient (API) CDMO
Figure 32. Biologics CDMO
Figure 33. Finished Dosage Form (FDF) CDMO
Figure 34. Others
Figure 35. World Life Science CDMO Market Size Market Share by Type (2019-2030)
Figure 36. World Life Science CDMO Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Life Science CDMO Market Size Market Share by Application in 2023
Figure 38. Pharmaceutical
Figure 39. Clinical
Figure 40. Research
Figure 41. Life Science CDMO Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World Life Science CDMO Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Life Science CDMO Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Life Science CDMO Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Life Science CDMO Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Life Science CDMO Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Life Science CDMO Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Life Science CDMO Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Life Science CDMO Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Life Science CDMO Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Life Science CDMO Players in 2023
Table 12. World Life Science CDMO Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Life Science CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Life Science CDMO Player
Table 15. Life Science CDMO Market: Company Product Type Footprint
Table 16. Life Science CDMO Market: Company Product Application Footprint
Table 17. Life Science CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Life Science CDMO Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Life Science CDMO Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Life Science CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Life Science CDMO Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Life Science CDMO Revenue Market Share (2019-2024)
Table 23. China Based Life Science CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Life Science CDMO Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Life Science CDMO Revenue Market Share (2019-2024)
Table 26. Rest of World Based Life Science CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Life Science CDMO Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Life Science CDMO Revenue Market Share (2019-2024)
Table 29. World Life Science CDMO Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Life Science CDMO Market Size by Type (2019-2024) & (USD Million)
Table 31. World Life Science CDMO Market Size by Type (2025-2030) & (USD Million)
Table 32. World Life Science CDMO Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Life Science CDMO Market Size by Application (2019-2024) & (USD Million)
Table 34. World Life Science CDMO Market Size by Application (2025-2030) & (USD Million)
Table 35. Lonza Group Basic Information, Area Served and Competitors
Table 36. Lonza Group Major Business
Table 37. Lonza Group Life Science CDMO Product and Services
Table 38. Lonza Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Lonza Group Recent Developments/Updates
Table 40. Lonza Group Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Life Science CDMO Product and Services
Table 44. Thermo Fisher Scientific Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Catalent Basic Information, Area Served and Competitors
Table 48. Catalent Major Business
Table 49. Catalent Life Science CDMO Product and Services
Table 50. Catalent Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Catalent Recent Developments/Updates
Table 52. Catalent Competitive Strengths & Weaknesses
Table 53. WuXi Biologics Basic Information, Area Served and Competitors
Table 54. WuXi Biologics Major Business
Table 55. WuXi Biologics Life Science CDMO Product and Services
Table 56. WuXi Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. WuXi Biologics Recent Developments/Updates
Table 58. WuXi Biologics Competitive Strengths & Weaknesses
Table 59. Samsung Biologics Basic Information, Area Served and Competitors
Table 60. Samsung Biologics Major Business
Table 61. Samsung Biologics Life Science CDMO Product and Services
Table 62. Samsung Biologics Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Samsung Biologics Recent Developments/Updates
Table 64. Samsung Biologics Competitive Strengths & Weaknesses
Table 65. Siegfried Basic Information, Area Served and Competitors
Table 66. Siegfried Major Business
Table 67. Siegfried Life Science CDMO Product and Services
Table 68. Siegfried Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Siegfried Recent Developments/Updates
Table 70. Siegfried Competitive Strengths & Weaknesses
Table 71. Fujifilm Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 72. Fujifilm Diosynth Biotechnologies Major Business
Table 73. Fujifilm Diosynth Biotechnologies Life Science CDMO Product and Services
Table 74. Fujifilm Diosynth Biotechnologies Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Fujifilm Diosynth Biotechnologies Recent Developments/Updates
Table 76. Fujifilm Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 77. Lars Petersen Basic Information, Area Served and Competitors
Table 78. Lars Petersen Major Business
Table 79. Lars Petersen Life Science CDMO Product and Services
Table 80. Lars Petersen Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Lars Petersen Recent Developments/Updates
Table 82. Lars Petersen Competitive Strengths & Weaknesses
Table 83. Recipharm Basic Information, Area Served and Competitors
Table 84. Recipharm Major Business
Table 85. Recipharm Life Science CDMO Product and Services
Table 86. Recipharm Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Recipharm Recent Developments/Updates
Table 88. Recipharm Competitive Strengths & Weaknesses
Table 89. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 90. Boehringer Ingelheim Major Business
Table 91. Boehringer Ingelheim Life Science CDMO Product and Services
Table 92. Boehringer Ingelheim Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Boehringer Ingelheim Recent Developments/Updates
Table 94. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 95. MilliporeSigma Basic Information, Area Served and Competitors
Table 96. MilliporeSigma Major Business
Table 97. MilliporeSigma Life Science CDMO Product and Services
Table 98. MilliporeSigma Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. MilliporeSigma Recent Developments/Updates
Table 100. MilliporeSigma Competitive Strengths & Weaknesses
Table 101. Aenova Group Basic Information, Area Served and Competitors
Table 102. Aenova Group Major Business
Table 103. Aenova Group Life Science CDMO Product and Services
Table 104. Aenova Group Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Aenova Group Recent Developments/Updates
Table 106. Aenova Group Competitive Strengths & Weaknesses
Table 107. AGC Parma Chemicals Basic Information, Area Served and Competitors
Table 108. AGC Parma Chemicals Major Business
Table 109. AGC Parma Chemicals Life Science CDMO Product and Services
Table 110. AGC Parma Chemicals Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. AGC Parma Chemicals Recent Developments/Updates
Table 112. AGC Parma Chemicals Competitive Strengths & Weaknesses
Table 113. GenScript Basic Information, Area Served and Competitors
Table 114. GenScript Major Business
Table 115. GenScript Life Science CDMO Product and Services
Table 116. GenScript Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. GenScript Recent Developments/Updates
Table 118. GenScript Competitive Strengths & Weaknesses
Table 119. Novartis Basic Information, Area Served and Competitors
Table 120. Novartis Major Business
Table 121. Novartis Life Science CDMO Product and Services
Table 122. Novartis Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Novartis Recent Developments/Updates
Table 124. Sai Life Sciences Basic Information, Area Served and Competitors
Table 125. Sai Life Sciences Major Business
Table 126. Sai Life Sciences Life Science CDMO Product and Services
Table 127. Sai Life Sciences Life Science CDMO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 128. Global Key Players of Life Science CDMO Upstream (Raw Materials)
Table 129. Life Science CDMO Typical Customers
LIST OF FIGURE
Figure 1. Life Science CDMO Picture
Figure 2. World Life Science CDMO Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Life Science CDMO Total Market Size (2019-2030) & (USD Million)
Figure 4. World Life Science CDMO Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Life Science CDMO Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Life Science CDMO Revenue (2019-2030) & (USD Million)
Figure 13. Life Science CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 16. World Life Science CDMO Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 18. China Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 23. India Life Science CDMO Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Life Science CDMO by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Life Science CDMO Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Life Science CDMO Markets in 2023
Figure 27. United States VS China: Life Science CDMO Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Life Science CDMO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Life Science CDMO Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Life Science CDMO Market Size Market Share by Type in 2023
Figure 31. Active Pharmaceutical Ingredient (API) CDMO
Figure 32. Biologics CDMO
Figure 33. Finished Dosage Form (FDF) CDMO
Figure 34. Others
Figure 35. World Life Science CDMO Market Size Market Share by Type (2019-2030)
Figure 36. World Life Science CDMO Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 37. World Life Science CDMO Market Size Market Share by Application in 2023
Figure 38. Pharmaceutical
Figure 39. Clinical
Figure 40. Research
Figure 41. Life Science CDMO Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
